HDAC1

Histone Deacetylase 1 (HDAC1) is an enzyme that in humans is encoded by the HDAC1 gene located on chromosome 1. HDAC1 belongs to the class I of the histone deacetylase family, a group of enzymes that play a crucial role in modifying chromatin structure and regulating gene expression. By removing acetyl groups from histone proteins, HDAC1 alters the accessibility of the DNA wrapped around histones, thereby repressing transcription. This activity is essential for cell cycle progression, differentiation, and development, as well as the maintenance of genomic stability.

Function[edit | edit source]

HDAC1 is involved in the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3, and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression, and developmental events. HDAC1's activity is regulated by its interaction with co-repressors and co-activators. It forms complexes with proteins such as mSin3A, N-CoR, and SMRT, which are necessary for the transcriptional repression activity of HDAC1.

Clinical Significance[edit | edit source]

Alterations in HDAC1 expression and function have been associated with various forms of cancer, making it a target for cancer therapy. Inhibitors of HDAC1, known as HDAC inhibitors (HDACIs), are being explored for their potential to induce cell cycle arrest, differentiation, and apoptosis in cancer cells. Beyond oncology, HDAC1's role in neurodegenerative diseases, such as Huntington's and Alzheimer's, is under investigation, with HDAC inhibitors showing promise in animal models of these diseases.

HDAC Inhibitors[edit | edit source]

HDAC inhibitors are a class of compounds that interfere with the function of HDACs. Given the role of HDAC1 in repressing gene expression, HDAC inhibitors can reactivate silenced genes in cancer cells and induce effects such as cell cycle arrest, apoptosis, and differentiation. Several HDAC inhibitors have been approved for the treatment of specific types of cancer, and many others are in various stages of clinical trials.

Interactions[edit | edit source]

HDAC1 has been shown to interact with a variety of proteins, including transcription factors, co-repressors, and other histone deacetylases. These interactions are critical for the regulation of HDAC1 activity and, consequently, for the control of gene expression and cell function.